CLIENT: Enterprise Ireland

​

Enterprise Ireland reveals the Biotechnology Strategy Brochure to develop Ireland's biotechnology and life sciences industry.

​

The fund is a partnership between
Enterprise Ireland and Seroba BioVentures. The fund has a target size of €25m. It has already completed the first-round closing of €15m and €7.5m has been provided by Enterprise Ireland under its seed and venture capital initiative.

​

It will be managed by Seroba BioVentures.

​

The brochure was designed to highlight the benefits of maximising the creation of new biotechnology companies in Ireland.